A RANDOMIZED TRIAL TO EVALUATE THE EFFECT OF SCHEDULE ON THE ACTIVITY OF ETOPOSIDE IN SMALL-CELL LUNG-CANCER

被引：0
|
作者：
HARVEY, VJ
SLEVIN, ML
CLARK, PI
OSBORNE, RJ
MALIK, S
WOOD, CD
JOEL, SP
MALPAS, JS
WRIGLEY, PFM
机构：
[1] ST BARTHOLOMEWS HOSP,DEPT MED ONCOL,LONDON EC1A 7BE,ENGLAND
[2] HACKNEY HOSP,DEPT MED ONCOL,LONDON,ENGLAND
来源：
MEDICAL AND PEDIATRIC ONCOLOGY | 1987年 / 15卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：152 / 152
页数：1
相关论文
共 50 条
  • [21] SEQUENCING AND SCHEDULE EFFECTS OF CISPLATIN PLUS ETOPOSIDE IN SMALL-CELL LUNG-CANCER - RESULTS OF A NORTH CENTRAL CANCER-TREATMENT GROUP RANDOMIZED CLINICAL-TRIAL
    MAKSYMIUK, AW
    JETT, JR
    EARLE, JD
    SU, JQ
    DIEGERT, FA
    MAILLIARD, JA
    KARDINAL, CG
    KROOK, JE
    VEEDER, MH
    WIESENFELD, M
    TSCHETTER, LK
    LEVITT, R
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (01) : 70 - 76
  • [22] RANDOMIZED TRIAL OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND VINCRISTINE VERSUS CISPLATIN AND ETOPOSIDE VERSUS ALTERNATION OF THESE REGIMENS IN SMALL-CELL LUNG-CANCER
    FUKUOKA, M
    FURUSE, K
    SAIJO, N
    NISHIWAKI, Y
    IKEGAMI, H
    TAMURA, T
    SHIMOYAMA, M
    SUEMASU, K
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (12) : 855 - 861
  • [23] CISPLATIN AND ETOPOSIDE VERSUS CYCLOPHOSPHAMIDE, EPIRUBICIN AND VINCRISTINE IN SMALL-CELL LUNG-CANCER - A RANDOMIZED STUDY
    VERONESI, A
    CARTEI, G
    CRIVELLARI, D
    MAGRI, MD
    DELLAVALENTINA, M
    FOLADORE, S
    TROVO, MG
    NASCIMBEN, O
    SIBAU, A
    TALAMINI, R
    MONFARDINI, S
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (10) : 1474 - 1478
  • [24] ORAL IFOSFAMIDE AND ETOPOSIDE FOR SMALL-CELL LUNG-CANCER (SCLC) PATIENTS
    CERNY, T
    THATCHER, N
    LIND, M
    CARROLL, K
    BULLETIN EUROPEEN DE PHYSIOPATHOLOGIE RESPIRATOIRE-CLINICAL RESPIRATORY PHYSIOLOGY, 1986, 22 : S101 - S101
  • [25] ADRIAMYCIN, CYCLOPHOSPHAMIDE AND ETOPOSIDE (ACE) IN THE TREATMENT OF SMALL-CELL LUNG-CANCER
    ARDIZZONI, A
    CANOBBIO, L
    PRONZATO, P
    REPETTO, L
    SERRANO, J
    BENVENUTO, F
    SIMONASSI, C
    BARACCO, F
    FARAVELLI, B
    NOSENZO, M
    ROSSO, R
    CHEMIOTERAPIA, 1986, 5 (06): : 416 - 419
  • [26] CARBOPLATIN, ETOPOSIDE, AND IFOSFAMIDE AS INTENSIVE CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER
    SMITH, IE
    PERREN, TJ
    ASHLEY, SA
    WOODIWISS, J
    FORGESON, GV
    YARNOLD, JR
    FORD, HT
    JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (05) : 899 - 905
  • [27] CHEMOTHERAPY WITH VINCRISTINE/IFOSFAMIDE/CARBOPLATIN/ETOPOSIDE IN SMALL-CELL LUNG-CANCER
    LORIGAN, P
    LEE, SM
    BETTICHER, D
    WOODHEAD, M
    WEIR, D
    HANLEY, S
    HARDY, C
    THATCHER, N
    SEMINARS IN ONCOLOGY, 1995, 22 (03) : 32 - 41
  • [28] ETOPOSIDE AND SPLIT-DOSE CISPLATIN IN SMALL-CELL LUNG-CANCER
    WILKE, H
    ACHTERRATH, W
    SCHMOLL, HJ
    GUNZER, U
    PREUSSER, P
    LENAZ, L
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (05): : 572 - 578
  • [29] COMBINATION CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, EPIRUBICIN AND ETOPOSIDE IN SMALL-CELL LUNG-CANCER
    JASSEM, J
    KARNICKAMLODKOWSKA, H
    JASSEM, E
    SLUPEK, A
    ZYCH, J
    WIATR, E
    MALAK, S
    MOSANTKOWIAK, R
    SZYMACZEKMEYER, L
    PILARSKAMACHOWICZ, A
    JERECZEK, B
    LUNG CANCER, 1994, 11 (3-4) : 283 - 291
  • [30] COMBINATION CIS-PLATINUM AND ETOPOSIDE IN SMALL-CELL LUNG-CANCER
    NATALE, RB
    WITTES, RE
    CANCER TREATMENT REVIEWS, 1982, 9 : 91 - 94
12345